MAX-40279 hemifumarate 是FLT3激酶和FGFR激酶的双重有效抑制剂。MAX-40279 hemifumarate 具有研究急性髓性白血病 (AML) 的潜力 (信息提取自专利 WO2021180032A1)。

MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032) [1].

2388506-43-0

C26H27FN6O5S

554.59

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years